Demiurge AI discovers the clinical benefits and risks of Remdesivir, Chloroquine, and PI3K inhibitors against 2019 novel Coronavirus (COVID-19) | Demiurge Technologies

“Demiurge is responding to the outbreak of the 2019 novel coronavirus (COVID-19) through the appropriate use of our AI platform of discovering novel therapeutic solutions and predicting clinical trial outcomes. We are conducting deep analyses of published studies and clinical data on COVID-19 against our precise broad-spectrum virology models.

In addition to the previous discoveries of multiple PI3K inhibitors as novel therapeutic options for COVID-19, we hereby officially announce further discoveries of the clinical benefits and risks of Remdesivir, Chloroquine, and PI3K inhibitors against COVID-19: […]”

Read the full article @ Demiurge Technologies:

Demiurge AI Discovers the Clinical Benefits and Risks of Remdesivir, Chloroquine, and PI3K inhibitors against 2019 Novel Coronavirus (COVID-19)
SWITZERLAND, SUNDAY, 23 FEBRUARY 2020 7:35 AM CET Demiurge is responding to the outbreak of the 2019 novel coronavirus (COVID-19) through the appropriate use of our AI platform of

1,258 thoughts on “Demiurge AI discovers the clinical benefits and risks of Remdesivir, Chloroquine, and PI3K inhibitors against 2019 novel Coronavirus (COVID-19) | Demiurge Technologies”

  63. Unlock the full potential of your digital assets with imToken. Fast, secure, and user-friendly – the ultimate crypto wallet. | 用imToken释放您数字资产的全部潜力。快速、安全、用户友好——终极加密钱包。https://www.imtokend.com
    i70cesxcne

    Reply

  100. Wow, marvelous weblog layout! How lengthy have you ever been blogging for?

    you made blogging glance easy. The entire look of
    your site is great, let alone the content! You can see similar here
    sklep internetowy

    Reply

  136. I truly appreciate this post. I’ve been looking everywhere for this! Thank goodness I found it on Bing. You have made my day! Thanks again!

    Reply